financetom
Business
financetom
/
Business
/
Fintech firm Stripe valued at $91.5 billion in latest tender offer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fintech firm Stripe valued at $91.5 billion in latest tender offer
Feb 27, 2025 6:27 AM

Feb 27 (Reuters) - Stripe on Thursday announced a tender

offer for employees and shareholders that valued the company at

$91.5 billion, nearly 41% higher than its valuation a year ago,

potentially delaying the fintech firm's ambitions of going

public.

The deal signals the strong recovery of the global

venture capital sector, as central banks have started to cut

interest rates amid subdued inflation and strong economic data.

"Stripe was profitable in 2024, and we expect to be so

in 2025 and beyond," co-founders John Collison and Patrick

Collison said in their annual letter published on Thursday.

The payments processing company was valued at $65 billion in

a deal last year, which allowed employees to cash out their

stock.

At its peak, Stripe was valued at $95 billion in 2021.

The company serves a variety of high-profile customers,

including Elon Musk-led social media platform X, Amazon ( AMZN )

, car rental firm Hertz Global ( HTZ ) and grocery

delivery app Instacart.

Stripe, which has headquarters in San Francisco and

Dublin, allows companies to accept payments, send payouts and

automate financial processes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025
NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025
Oct 23, 2025
ZURICH, Oct. 23, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NLS or the Company), a Swiss clinical-stage biopharmaceutical company focused on central nervous system (CNS) disorders, and Kadimastem Ltd. (TASE: KDST) (Kadimastem), an advanced clinical-stage cell therapy company developing treatments for neurodegenerative diseases and diabetes, today announced an update regarding the proposed merger (the Merger). On October 21, 2025, NLS received an approval...
Tesla's big gamble that introducing new models no longer matters
Tesla's big gamble that introducing new models no longer matters
Oct 23, 2025
(Reuters) -Tesla's groundbreaking 2017 Model 3 electric sedan, followed by a taller Model Y variant, ushered in the era of mass-market electric cars, made Tesla the world's most valuable automaker and CEO Elon Musk the world's richest man. But years later, Tesla's stalling car business remains almost entirely dependent on that one breakthrough - and it may continue to be...
Form 8.3 - ME Group International Plc
Form 8.3 - ME Group International Plc
Oct 23, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Montanaro Asset Management Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
IBM shares fall as cloud slowdown triggers investor anxiety
IBM shares fall as cloud slowdown triggers investor anxiety
Oct 23, 2025
By Akriti Shah (Reuters) -IBM ( IBM ) shares dropped nearly 7% in premarket trading on Thursday after a decline in growth in its core cloud software segment spooked investors over Big Blue's ability to seize the booming demand for cloud services. Sluggish expansion in IBM's ( IBM ) cloud business, a unit of its software segment, raised fresh concerns...
Copyright 2023-2026 - www.financetom.com All Rights Reserved